Bright Minds Biosciences DRUG Income Statement (2019-2026)

NASDAQ DRUG
$49.82 +0.08 (+0.16%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Bright Minds Biosciences Quarterly Income Statement

Periods 25 quarters
Latest Jun 2026

Bright Minds Biosciences reported net income of -$0.00B for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.00B0.00B0.00B0.00B0.01B
Operating items
Research & DevelopmentR&D
5,015.89B0.00B0.00B0.00B9,339.68B0.00B0.00B0.00B3,729.61B0.00B0.00B-0.00B865.01B0.00B0.00B0.00B0.00B0.00B0.01B0.01B
Share-based Compensation (IS)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Selling, General & AdministrativeSG&A
156.60B0.00B0.00B0.00B366.69B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Operating ExpensesOther Opex
563.99B0.00B0.00B0.00B498.53B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating ExpensesOpex
5,172.49B0.00B0.00B0.00B9,706.38B0.00B0.00B0.00B3,729.61B0.00B0.00B-0.00B865.01B0.00B0.00B0.00B0.00B0.00B0.01B0.01B
EBIT
-0.00B-0.01B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B-0.01B-0.00B
Non-operating items
Non Operating Investment Income
-0.00B-0.00B0.00B0.00B-0.01B
Interest & Investment IncomeInt & Inv Inc
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating IncomeOther Non Op Inc.
-122.42B0.00B0.00B-0.00B-9.32B0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B
Net income details
EBT
-0.00B-0.01B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B-0.01B-0.00B
Tax ProvisionsTaxes
0.00B-0.00B
Profit After TaxPAT
-0.00B-0.01B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B-0.01B-0.00B
Income from Continuing OperationsIncome (Continuing)
-0.00B-0.01B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B-0.01B-0.00B
Consolidated Net IncomeConsol Net Inc.
-0.00B0.00B-11474.32B0.00B0.00B-0.00B-0.01B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B0.02B-0.00B
Income towards Parent CompanyParent Net Inc
-6872.25B0.00B-0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B0.02B-0.00B
Net Income towards Common StockholdersNet Income
-6872.25B0.00B-0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B0.02B-0.00B
Additional items
EPS (Basic)
-0.00B2.15-1.971.160.920.700.61-0.440.290.33-0.110.08-0.480.010.540.88-1.29-0.873.02-0.25
EPS (Diluted)
-0.00B2.15-1.971.160.920.700.61-0.440.290.33-0.110.08-0.480.010.540.88-2.06-1.394.82-0.40
Shares Outstanding
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
EBITDA
-0.00B-0.01B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.01B-0.01B-0.01B-0.00B
Tax Rate
4.31

Bright Minds Biosciences Income Statement API

Pull Bright Minds Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DRUG&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY